SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-305903
Filing Date
2022-12-15
Accepted
2022-12-15 16:15:58
Documents
13
Period of Report
2022-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d395198d8k.htm   iXBRL 8-K 27253
2 EX-99.1 d395198dex991.htm EX-99.1 11822
  Complete submission text file 0001193125-22-305903.txt   173127

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vigl-20221211.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20221211_lab.xml EX-101.LAB 19501
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20221211_pre.xml EX-101.PRE 12163
7 EXTRACTED XBRL INSTANCE DOCUMENT d395198d8k_htm.xml XML 3590
Mailing Address 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142
Business Address 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 221465007
SIC: 2836 Biological Products, (No Diagnostic Substances)